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Abstract
As substance use increases in the United States, the number of neonates born with
neonatal abstinence syndrome (NAS) has also increased from women using substances during
pregnancy. Consequently, the healthcare industry has noticed a significant rise in the number of
neonates born with NAS withdrawal symptoms, increasing healthcare costs and need for
evidence-based practice. The purpose of this systematic review is to appraise the evidence
regarding the effects of supplemental nonpharmacological interventions, specifically
breastfeeding and rooming-in, compared to standard pharmacological treatment, on outcomes in
neonates with NAS. Twenty peer-reviewed research studies conducted between 2010 and 2018
were obtained from scholarly databases. Studies were analyzed based on relevance to neonates
experiencing NAS symptoms and nonpharmacological interventions of breastfeeding and
rooming-in. Researchers consistently concluded that breastfeeding and rooming-in positively
impact NAS outcomes by decreasing the need for pharmacological treatment, severity of NAS
withdrawal symptoms, and length of stay.
Keywords: neonatal abstinence syndrome, opioids, pharmacological treatment,
nonpharmacological interventions, length of stay, LOS, neonatal outcomes, breastfeeding,
rooming-in
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Effects of Nonpharmacological Interventions on Outcomes in Neonates with Neonatal
Abstinence Syndrome: A Systematic Review
The United States is falling deeper into the midst of an intensifying opioid epidemic as
evidenced by 42,000 deaths from opioid overdoses in 2016, which is five times the number of
deaths in 1999 (Centers for Disease Control and Prevention [CDC], 2018). Women of
childbearing age constitute a large portion of those suffering from opioid use. In fact, nearly onethird of those people being treated for opioid addiction are women of the childbearing age
(O’Connor, Collett, Alto, & O’Brien, 2013). This is a significant problem because 21,732
neonates in 2012 were born with opiate withdrawal symptoms; therefore, an addicted neonate is
born every 25 minutes (National Institute on Drug Abuse, 2015).
Substance abuse during pregnancy leads to the development of neonatal abstinence
syndrome (NAS) in neonates. NAS is classified as the possible withdrawal syndrome that
neonates may experience due to in-utero exposure to opioids and is “characterized by
hyperirritability of the central nervous, the gastrointestinal, the respiratory and the autonomic
nervous systems” (Welle-Strand et al., 2013, p. 1060). Various consequences affecting addicted
mothers and neonates include but are not limited to: intrauterine growth restriction, preterm
rupture of membranes, placental insufficiency, premature birth, postpartum hemorrhage, and
potentially perinatal mortality (O’Connor et al., 2013). These perinatal and postpartum
complications lead to high-risk pregnancies and postpartum periods, causing detrimental effects
on neonates and mothers. Neonates at risk for NAS are carefully monitored for signs and
symptoms of withdrawal. The effects of NAS in the immediate postpartum period include
increased chance of disrupted mother-neonate bonding, sleeping and feeding difficulties, weight
loss, and seizures (Bhatt-Mehta, Ng, & Schumacher, 2014). These problems often make the
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neonatal transition difficult and may result in admission to neonatal intensive care units (NICU)
(McKnight et al., 2016).
Moreover, the rise in neonates with NAS has consequences for the healthcare industry,
increasing length of hospital stays and costs. With increased NAS incidence and treatment, the
costs of care per neonate rose 30% to approximately $69,000, from 2009 to 2012, resulting in
$1.5 billion in additional hospital charges overall (Crook & Brandon, 2017). Furthermore, as
many as 50% of neonates with NAS are sent to NICUs, consequently diminishing available beds
for neonates experiencing other indispositions (Loudin et al., 2017). Newborns with NAS
symptoms are often treated in NICUs to ensure neonatal well-being and symptom management
(Holmes et al., 2016). When neonates are admitted to NICUs, costs per case can be as high as
$93,000 compared to $20,000 for standard neonatal care (Howard et al., 2017). Additionally,
less costly nonpharmacological interventions are difficult to implement when neonates are
treated in NICUs due to the mother-neonate separation.
Within the first postnatal days, neonates exposed to opioids in utero begin to express
withdrawal symptoms; thus, further action is needed to avoid major complications (Hünseler,
Brückle, Roth, & Kribs, 2013). Withdrawal symptoms in neonates are quantified using the
Finnegan scale, which is a systematic method of scoring 21 signs that grade neonatal withdrawal
severity (Timpson, Killoran, Maranda, Picarillo, & Bloch-Salisbury, 2018). The Finnegan
Scoring System measures central nervous system symptoms, such as high-pitched crying, ease of
feeding, muscle tone, and temperature (McQueen, Murphy-Oikonen, Gerlach, & Montelpare,
2011). Nurses subjectively rate each sign with a numerical value from one to three, based on the
severity of the symptoms, and these values are added together for a total score. Three
consecutive scores greater than or equal to eight are indicative of NAS (O’Connor et al., 2013).
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Regarding the need for pharmacological treatment to relieve NAS symptoms, over half of
neonates exposed to opioids need such pharmacological intervention (Howard et al., 2017). The
first-line treatment for neonates expressing symptoms of NAS includes opiates, such as
methadone and buprenorphine (Hünseler et al., 2013). Methadone therapy is begun if neonates
score higher than eight on two consecutive occasions when using the Finnegan scale (Isemann,
Meinzen-Derr, & Akinbi, 2011). The pharmacological treatment of NAS with methadone may
cause hypertonicity, irritability, and disorganized sucking, further complicating neonates’
withdrawal symptoms and breastfeeding (Demirci, Bogen, & Klionsky, 2015). If neonates reach
maximum dosage of methadone and continue displaying signs of NAS withdrawal, phenobarbital
can be used as a second-line therapy (Howard et al., 2017). Eventually, pharmacological
treatment is weaned to the lowest dose and discontinued. Before neonates are discharged home,
they are monitored for 24 to 48 hours following completion of opioid replacement therapy
(Howard et al., 2017). Consequently, the use of pharmacologic therapy increases the length of
stay (LOS) in neonates with NAS.
Nurses may supplement treatment with nonpharmacological interventions, such as
breastfeeding and rooming-in, which have been found to promote bonding and attachment in
neonates and to decrease the severity of withdrawal symptoms (Newman et al., 2015; Pritham,
Paul, & Hayes, 2012). Benefits of these nurse-driven interventions include decreased costs and
fewer side effects. The purpose of this systematic review is to identify and critically appraise the
evidence regarding effects of supplemental nonpharmacological interventions, specifically
breastfeeding and rooming-in, compared to standard pharmacological treatment, on outcomes in
neonates with NAS withdrawal symptoms. This systematic review will answer the following
PICOT question: In neonates exposed to opioids in utero, how do supplemental
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nonpharmacological interventions, compared to standard pharmacological treatment alone, affect
neonatal outcomes directly after birth through discharge from the hospital? This systematic
review is significant to nurses because, with an increased number of pregnant women abusing
opioids, nurses have seen a fivefold increase in neonates expressing signs and symptoms of NAS
within the past 15 years (Schiff et al., 2018). Since pharmacotherapy is associated with side
effects and complications, nurses need to promote positive outcomes for neonates with NAS by
enhancing practice. This should be based on evidence regarding the effectiveness of nurseinitiated, nonpharmacological interventions.
Methods
The goal of the search was to identify studies that met inclusion criteria, specifically
where nonpharmacological treatment was provided and compared to standard care of neonates
with NAS. Common nonpharmacological interventions identified by the search were
breastfeeding and rooming-in, which consequently promote bonding and attachment in the early
phase of the NAS-affected neonates’ lives (Newman et al., 2015; Pritham et al., 2012). The
desired time period of outcomes was from the birth of the neonates to discharge from the
hospital. The studies were published between 2010 and 2018 and were found in the following
databases: CINAHL Plus with Full Text, MEDLINEPlus, PSYCHInfo, and SOCIndex.
After identifying pertinent nonpharmacological interventions, keywords included
neonatal abstinence syndrome, NAS, withdrawal, breastfeeding, rooming-in, and opioid
treatment. A search with keywords of ‘neonatal abstinence syndrome or NAS or withdrawal’
and ‘breastfeeding or rooming-in’ resulted in 499 articles. ‘Neonatal abstinence syndrome’ and
‘breastfeeding’ and ‘opioid treatment’ yielded 20 publications. ‘NAS or neonatal abstinence
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syndrome’ and ‘breastfeeding’ produced 5,002 publications. In addition, ‘NAS or neonatal
abstinence syndrome’ and ‘rooming-in’ produced 7,109 publications.
Additionally, the US National Library of Medicine’s PubMed Central (PMC) database
was searched. Keywords of ‘neonatal abstinence syndrome’ and ‘breastfeeding’ and ‘opioid
maintenance treatment’ produced 83 results. Lastly, Google Scholar databases were searched
with keywords of ‘rooming-in’ and ‘neonatal abstinence syndrome’, yielding 856 results, and
with ‘neonatal abstinence syndrome’ and ‘breastfeeding’ and ‘rooming-in’, resulting in 624
results.
At the beginning of the searching procedure, publications that were older than five years
were excluded using advanced search methods within the databases. Since retrieved publications
were limited in number within this time frame, criteria were extended to eight years. This
allowed for identification of more publications relevant to and answering the PICOT
question. Exclusion criteria included secondary sources, literature reviews, or meta-analyses;
therefore, only primary sources were included in the review. Publications were selected without
bias to show variation and inconsistencies that were present in findings.
Throughout the searches, many publications were carefully reviewed to determine if they
answered the PICOT question and discussed the impact of breastfeeding and rooming-in
compared with standard care of neonates with NAS. This was done by first analyzing the title of
each article and then, if applied to the research question, content was read for relevancy. After a
comprehensive review of all major relevant research, a total of 20 studies were included in this
systematic review.
Review of Literature
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The 20 studies obtained for this systematic review were carefully read to determine their
relevance to NAS symptoms and nonpharmacological interventions of breastfeeding and
rooming-in. The setting of the studies ranged from locations as close as Cincinnati, Ohio to as
far as Western Sydney and Norway. The most commonly used design was a comparison cohort,
generating level four evidence. In all but one study, researchers reviewed the medical records of
mothers and neonates who met inclusion and exclusion criteria and compared neonates who
received standard care to those who roomed-in with their mothers or were breastfed. In the study
that was the exception, researchers collected data with questionnaires from mothers who were
invited to participate in the study. Because many of these studies were performed by examining
medical records, prior documentation may not have been an accurate representation of the care
that was provided. Unlike consistent sampling and data collection methods across studies,
sample sizes varied greatly from only 11 up to 3,725 participants. This may limit researchers’
findings since small sample sizes are not as representative of the entire population. In the
following sections, breastfeeding interventions and outcomes in neonates with NAS will be
initially presented, followed by rooming-in interventions and outcomes in this
population. Intervention outcomes include pharmacological use, NAS symptoms and scores, and
LOS.
Breastfeeding
One major nonpharmacological intervention used to affect outcomes in neonates with
NAS is breastfeeding. Newborns’ optimal nutrition is maternal milk, and in general,
breastfeeding has positive impact on both the mothers’ and neonates’ health, as well as early
bonding and attachment (Welle-Strand et al., 2013). Additionally, the severity of NAS
symptoms are mitigated as maternal opioids are transferred in the breast milk (Demirci et al.,
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2015). The women included in these studies met certain requirements in order to breastfeed their
neonates (Schiff et al., 2018). For example, contraindications to breastfeeding included illicit
drug use, HIV, herpes lesions on the breasts, hepatitis C with nipples that are cracked and
bleeding, or other prescription medications that are transmitted through the breastmilk and
harmful to the neonates (Short, Gannon, & Abatemarco, 2016).
Across the 20 studies, researchers specified findings related to breastfeeding and how it
can affect neonates exhibiting NAS. For example, researchers in six studies found that
breastfeeding can decrease the need for pharmacological treatment (Grossman et al., 2017;
Hodgson & Abrahams, 2012; Liu, Juarez, Nair, & Nanan, 2015; O’Connor et al., 2013; WelleStrand et al., 2013; Yonke, Maston, Weitzen, & Leeman, 2018). Researchers in five studies also
found that breastfeeding reduced NAS scores and symptoms of neonates (Demirci et al., 2015;
Liu et al., 2015; McQueen et al., 2011; O’Connor et al., 2013; Welle-Strand et al., 2013). Lastly,
researchers of seven studies supported that breastfeeding can lead to a decreased average length
of stay in neonates with NAS (Crook & Brandon, 2017; Grossman et al., 2017; Isemann et al.,
2011; Pritham et al., 2012; Schiff et al., 2018; Short et al., 2016; Well-Strand et al., 2013).
Pharmacological therapy. Several researchers have found that breastfeeding diminishes
the need for pharmacological therapy with reductions ranging from 84% to 6.9% (Grossman et
al., 2017;Hodgson & Abrahams, 2012; Liu et al., 2015; O’Connor et al., 2013; Welle-Strand et
al., 2013; Yonke et al., 2018). In the study conducted by Yonke et al. (2018) of 228 neonates,
the percentage of neonates that were breastfed and required pharmacological intervention
decreased by 31.6% compared to the formula fed group. Similarly, in a study of 194 motherneonate dyads, Liu et al. (2015) found that by adhering mostly to breastfeeding during the early
postpartum period, NAS pharmacological treatment decreased by 37%. However, Welle-Strand
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et al. (2013) studied 124 neonates and concluded that only a 12% decreased need for
pharmacological treatment was associated with breastfed neonates versus non-breastfed
neonates. Additionally, O’Connor et al. (2013) studied 85 maternal-neonate pairs and found a
6.9% decreased need for pharmacotherapy.
NAS scores and symptoms. Researchers have consistently found that breastfeeding
delays the onset of NAS symptoms, lessens severity of symptoms, and overall decreases mean
NAS scores (Demirci et al., 2015; Liu et al., 2015; McQueen et al., 2011; O’Connor et al., 2013;
Welle-Strand et al., 2013). Several researchers examined the effects of breastfeeding in relation
to NAS scores. McQueen et al. (2011) used a modified Finnegan Scoring System and found that
breastfeeding reduced the Finnegan mean score in 28 neonates; the mean peak score of the
breastfed group was 4.9 versus formula-fed of 6.9. On the other hand, O’Connor et al. (2013)
discovered that of 85 neonates, the breastfed group in their study had a mean Finnegan peak
score of 8.83 versus 9.65 in the formula-fed group. Both research groups found that a score of
eight or above was less likely to occur in those neonates who were breastfed; thus,
pharmacological treatment with buprenorphine or methadone was not required (McQueen et al.,
2011; O’Connor et al., 2013). McQueen et al. (2011) found that 40.2% of formula-fed neonates
scored higher than eight on the Finnegan scale requiring pharmacological therapy, compared to
only 17% of breastfed neonates. NAS withdrawal scoring is subjective, which suggests that
Finnegan totals will vary based on the healthcare professional performing the assessment. This
identifies a limitation that must be considered when analyzing the relationships between NAS
scores and nonpharmacological intervention implementation.
Length of stay. Hospital LOS is another outcome of breastfeeding in neonates with
NAS (Crook & Brandon, 2017; Grossman et al., 2017; Isemann et al., 2011; Pritham et al., 2012;
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Schiff et al., 2018; Short et al., 2016; Welle-Strand et al., 2013). Differences in LOS for
breastfed neonates with NAS and those not breastfed ranged from 16.5 days to 2.78 days. In a
study of 287 neonates, Grossman et al. (2017) discovered that the average LOS decreased from
22.4 to 5.9 days when breastfeeding was implemented, which was a 74% reduction.
Additionally, the average LOS of 200 neonates who were only pharmacologically treated was
12.74 days longer than those who were breastfed (Crook & Brandon, 2017). However, in
contrast, Isemann et al. (2011) and Schiff et al. (2018) both discovered a three-day decrease in
LOS with sample sizes of 128 and 564 respectively, when breastfeeding was implemented.
Crook & Brandon (2017) also found that neonates solely breastfed had a 2.78-day shorter LOS
compared to those who received more than 50% human milk during hospitalization.
In the process of compiling research, hospital readmission was identified as a gap in
knowledge. Neonates were analyzed until hospital discharge; consequently, information on
whether or not neonates were readmitted to the hospital for further treatment was not available.
This is due to the collection method utilized in the studies, which limited data to the initial
hospital stay.
Rooming-In
Another method shown to improve outcomes in neonates with NAS is rooming-in, which
prevents separation of mothers and neonates during the critical time after birth and promotes
effective bonding and attachment (Newman et al., 2015). Howard et al. (2017) described
rooming-in as allowing neonates to stay in the same room as their mothers during
hospitalization. Neonates who room-in require less pharmacological therapy, experience less
severe signs of NAS, and have decreased hospital LOS (Newman et al., 2015). In general,
researchers have concluded that rooming-in positively affects neonates with NAS.
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Of the 20 studies in this systematic review, a majority discussed the impact of rooming-in
on neonates experiencing NAS symptoms. Researchers in seven studies clarified outcomes of
rooming-in with the need for pharmacological treatment (Hodgson & Abrahams, 2012; Holmes
et al., 2016; Howard et al., 2017; Hünseler et al., 2013; McKnight et al., 2016; Newman et al.,
2015; Saiki, Lee, Hannam, & Greenough, 2010). Researchers of two studies described the
effects of rooming-in on the severity of NAS scores and symptoms (Howard et al., 2017;
Hodgson & Abrahams, 2012). Researchers of eight studies also examined the effects of
rooming-in implementation on related hospital LOS (Abrahams et al., 2010; Grossman et al.,
2017; Holmes et al., 2016; Howard et al., 2017; Hünseler et al., 2013; McKnight et al., 2016;
Newman et al., 2015; Saiki et al., 2010).
Pharmacological therapy. Researchers have consistently reported that rooming-in
decreases the need for pharmacological treatment with methadone and buprenorphine (Holmes et
al., 2016; Howard et al., 2017; Hünsler et al., 2013; McKnight et al., 2016; Newman et al., 2015;
Saiki et al., 2010). The percentage of neonates requiring pharmacological treatment decreased,
ranging from 9% to 69% when rooming-in was implemented (Holmes et al., 2016; Hünsler et al.,
2013; McKnight et al., 2016; Newman et al., 2015; Saiki et al., 2010). Hünsler et al. (2013) and
Howard et al. (2017) found that rooming-in and maternal involvement reduced the need for
pharmacological therapy by 17% and 19% respectively, with sample sizes of 77 and 86
neonates. Additionally, researchers have examined other factors related to rooming-in that may
contribute to reduced need for pharmacotherapy. For example, Hünseler et al. (2013) found that
the increased mother-baby contact associated with rooming-in, such as cuddling and swaddling,
contributed to decreased need for pharmacological intervention. Also, because the postpartum
units are typically quieter than the neonatal units, the difference in environments could also
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influence the reduced need for pharmacotherapy (Saiki et al., 2010). The effectiveness of
rooming-in on pharmacological therapy may not be as accurate because, as stated above, other
factors such as swaddling and skin-to-skin contact occur simultaneously.
NAS scores and symptoms. Rooming-in has decreased Finnegan peak NAS scores and
has also been observed to decrease the severity of withdrawal symptoms in neonates suffering
with NAS symptoms (Hodgson & Abrahams, 2012; Howard et al., 2017). In a sample of 86
neonates, Howard et al. (2017) reported that average Finnegan NAS scores of roomed-in
neonates with increased maternal presence were significantly lower compared with those not
roomed-in, and the average NAS score was decreased by one point on the Finnegan scale
following 100% maternal presence. Similarly, according to Hodgson & Abrahams (2012), 295
neonates who were allowed to room-in with their mothers had a decreased rate of developing
NAS symptoms, and if the symptoms did develop, the need for treatment was reduced compared
to their non-breastfed counterparts.
Length of stay. Length of hospital stay in neonates with NAS is crucial, as extended
NICU stays are detrimental to early bonding efforts and family interactions (Abrahams et al.,
2010). Many researchers explored the effects of rooming-in on neonatal LOS and found
reductions ranging from 3.9 to 19 days (Grossman et al., 2017; Holmes et al., 2016; Howard et
al., 2017; Hünseler et al., 2013; McKnight et al., 2016; Newman et al., 2015; Saiki et al., 2010).
In a study conducted by Newman et al. (2015) to identify the effects of rooming-in on a sample
of 21 neonates, the LOS decreased from approximately 25 to 8 days when rooming-in was
implemented. Furthermore, reductions from 16.9 to 12.3 days were reported by Holmes et al.
(2016) in a study of 163 neonates. Additionally, a nine-day decrease in average LOS was noted
by Howard et al. (2017) when rooming-in was completed. These researchers discovered reduced
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LOS from rooming-in; however, Abrahams et al. (2010) found a ten-day increase in LOS from
NICU standard care to rooming-in. In this study, both neonates and mothers had longer stays;
the rooming-in LOS was 21 days and the standard care was 11 days. Based on findings in other
studies, it is unknown what factors caused this increased LOS.
Critical Appraisal of the Evidence
Limitations of Findings
Throughout this systematic review of the literature, breastfeeding and rooming-in were
analyzed to determine the effects on neonatal outcomes. Limitations include the Finnegan
Scoring System of NAS symptoms, pharmacological need with rooming-in, polysubstance abuse
and underreporting of maternal drug use, and factors influencing LOS.
First, a major limitation is the method by which the neonates’ symptoms are scored.
Some facilities implemented the Finnegan Scoring System while others used a modified system
focusing on fewer neonatal outcomes. However, even if the same Finnegan scale was used
across studies, the results would still be inconsistent because of the system’s subjectivity. For
example, if a neonate is experiencing tremors, one nurse may think that they are mild and rate
them accordingly; however, another nurse could think they were quite significant, rating them
much differently.
Another limitation of findings is related to the effects of rooming-in on the need for
pharmacological therapy. Rooming-in is difficult to be measured independently because other
factors are involved when rooming-in takes place. For instance, if the neonate is in the same
room as the mother, higher incidences of swaddling and skin-to-skin contact will most likely
occur compared to neonates who reside in the nursery. Therefore, it is hard to determine whether
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the actual rooming-in was beneficial, or if mother-neonate contact was correlated to differences
in pharmacological needs.
Maternal drug use is unclear due to the large variability as well as self-reporting of drug
use by the mothers included in the studies. Many studies concluded that drug use during
pregnancy was often underreported and some mothers used multiple drugs simultaneously,
ultimately leading to inaccurate data and different symptom presentation in neonates after birth
(Bhatt-Mehta et al., 2014; Liu et al., 2015; McKnight et al., 2016; O’Connor et al., 2013; Pritham
et al., 2012).
Additionally, it was not possible to accurately determine factors influencing neonatal
LOS. In some of the studies, rooming-in and breastfeeding decreased the LOS (Grossman et al.,
2017; Holmes et al., 2016; Howard et al., 2017; Hünseler et al., 2013; McKnight et al., 2016;
Newman et al., 2015; Saiki et al., 2010); however, in one study, the LOS was considerably
greater in the rooming-in group compared to those who received standard care (Abrahams et al.,
2010). As a result, other factors may have influenced this change that were not specified in the
studies. Plus, due to the data collection method focusing only on neonates’ initial hospital stay,
data on readmission for further treatment was limited.
Validity and Reliability of Methods
In the studies for this systematic review, validity and reliability varied. Nearly all the
studies were retrospective, which posed questions regarding the validity of the reports;
retrospective studies rely on past information that was documented, which could be interpreted
incorrectly. Additionally, retrospective studies lack randomization since inclusion criteria is
determined by the researchers.
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Reliability is another issue that must be considered to determine whether the findings are
accurate. In many of the studies, maternal drug use was self-reported, which could have led to
underreporting and data alteration. Furthermore, studies with larger sample sizes are more
reliable, decreasing the margin of error and increasing generalizability (Demirici et al., 2015).
Another factor contributing to decreased reliability is the NAS symptom scoring tools which
were different across the studies. Several studies used the Finnegan Scoring System (Grossman
et al., 2017; Howard et al., 2017; Hunseler et al., 2013; Isemann et al., 2011; Liu et al., 2015;
Newman et al., 2015; O’Connor et al., 2013) where others used a modified Finnegan Scoring
System (Holmes et al., 2016; McKnight et al., 2016; McQueen et al., 2011) or other methods
(Demirci et al., 2015; Short et., 2016; Welle-Strand et al., 2013).
Limitations Across Studies
Across studies, there were limitations identified that may have impacted the study
processes. An important limitation is small sample sizes, which can prevent accurate results.
Throughout the process of identifying articles for the systematic review, there was a limited
number of available studies published within five years. Therefore, search criteria were
extended to eight years to allow for identification of additional research.
Maternal situations should also be analyzed as the methods of study may have prevented
certain outcomes and interventions. If a randomized method was used, mothers would have been
told whether or not to breastfeed, which would be unethical. Additionally, some of the mothers
were not able to breastfeed due to illicit drug use, HIV, herpes lesions on the breasts, hepatitis C
with nipples that are cracked and bleeding, or other prescription medications (Short et al., 2016).
Lastly, some studies did not list whether the mothers had used methadone, buprenorphine, or
another medication-assisted treatment, which could have altered results.
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Synthesis of the Evidence
From this systematic review, evidence was critically appraised to determine the current
state of science. The results of the literature review all pointed to the positive effects of
rooming-in and breastfeeding, except for one article (Abrahams et al., 2010). Due to the
consistency of the findings, these studies are an accurate representation of current interventions
that can be used to promote positive effects in neonates with NAS.
Recommendations
After an extensive review of research, potential practice and research implications for
future studies were determined. Many of these studies proved that breastfeeding and rooming-in
methods of nonpharmacological treatment have been efficient in reducing the need for
pharmacological treatment, decreasing the overall length of stay, and minimizing the NAS signs
and symptoms displayed by neonates. Therefore, breastfeeding and rooming-in should be
recommended and encouraged by all healthcare professionals.
First, it is recommended that a standard screening process should be developed for
neonates who are at risk of developing NAS and mothers who have a history of substance abuse.
In addition to this screening process, mothers should be encouraged to take part in an educational
program to teach them the benefits of prenatal preventative measures rather than reactive
measures requiring symptom management after birth. These mothers should also be educated on
the benefits of nonpharmacological measures such as breastfeeding and rooming-in and the
positive impact they have on neonatal outcomes. Extra support and education may be needed for
these high-risk mothers that encounter stigmatization due to their substance abuse. From this, it
is important that medical treatment, resources, and classroom teaching should be made readily
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available throughout the community or in local hospitals to increase the incidence of mothers
who stop or decrease the abuse of illicit substances.
Another recommendation is to create an atmosphere within the hospital that encourages
rooming-in for neonates showing signs of withdrawal. Nurses and doctors on the postpartum
floors should be given special education on caring for neonates who are experiencing NAS
withdrawal symptoms so they can provide appropriate care. Furthermore, implementation of a
standardized scoring method, such as a modified or improved Finnegan system, should be
considered to determine when symptoms are too severe that neonates can no longer be treated on
a normal postpartum floor. This may help to alleviate overcrowded NICUs, especially as
neonates with NAS are becoming more prevalent with a rise in drug abuse.
Future studies that could advance nursing practice in this area should be focused on
identifying childbearing women’s preconceived beliefs about breastfeeding and addressing these
fears and factors that inhibit its practice. Future studies should be done to determine why women
choose not to breastfeed and to identify specific factors that prevent them from continuing
breastfeeding outside of the hospital setting. Healthcare providers need to address these factors
to increase breastfeeding in this at-risk population in order to decrease NAS withdrawal in
neonates. In addition, healthcare providers need to stress the importance and impact that
breastfeeding can have on NAS withdrawal severity to mothers during prenatal visits. Because it
has been concluded that breastfeeding prevalence is higher in women who room-in with their
neonates, future studies should include a statistical examination of the relationship between
rooming-in and breastfeeding rates. Additionally, at-risk mothers may also need extra support
and guidance to help initiate the breastfeeding process; therefore, a lactation consultant may be
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effective in assisting and educating the mother, as well as providing encouragement to continue
breastfeeding.
In regard to the research design, future studies should collect data prospectively rather
than retrospectively. Additionally, studies should have larger sample sizes to prove their
reliability and to make larger conclusions about the populations being studied. Regarding the
signs and symptoms of NAS, studies should not solely focus on the neonatal period but should
extend criteria in order to follow the child through the developmental process. A longer study
period would have benefits of identifying how NAS affects its subjects later in life related to
growth and mental capabilities.
Conclusion
Breastfeeding and rooming-in are beneficial for neonates who are experiencing
symptoms of NAS. From the studies analyzed in this systematic review, many positive
outcomes were measured as a result of breastfeeding and rooming-in implementation such as
decreased use of pharmacological therapy, NAS scores and symptoms, and LOS. However,
there are many additional factors that need to be identified and quantified in future studies as
well as interventions and programs that can be implemented to decrease NAS prevalence in
childbearing mothers who abuse substances.
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infants suffering from
NAS.
Research Question:
Does rooming-in along
with breastfeeding
affect the length of stay
of infants affected with
neonatal abstinence
syndrome, as well as
decreasing the need for
pharmacological
treatment?
Purpose Statement: The
purpose of this study
was to examine the
effects of breastfeeding
on the withdrawal
symptoms of infants of
mothers on methadone
therapy.
Research Question: Do
infants exposed to
opioids in utero who are
breastfed by mothers on
methadone, have
decreased symptoms of
NAS when compared

Setting:
Kingston
General Hospital
in Canada

Sampling
method: All
patient charts
that met criteria

31
Design:
Retrospective
comparison
cohort study
Level of
Evidence: IV

Neonates who
participated in
rooming-in with
their mothers
required less
pharmacological
treatment and
had shorter
lengths of stay in
the hospital.

Nurses should
promote rooming-in
and provide
education about the
benefits of roomingin and the reduced
need for
pharmacological
treatment.

There was no theoretical
framework involved in
this study. The sample
size was insufficient, and
the study was
retrospective as
evidenced by chart
reviews from the past. A
very small sample size
related to rooming-in was
noted so any accurate
conclusions were able to
be drawn. The mothers
self-reported on their
drug use, which is not
reliable.

Breastfed infants
had overall
lower NAS
scores compared
to formula-fed
infants. This
suggests that
there is an
increased need
for
pharmacological
treatment in the
absence of
breastfeeding.

Nurses should
provide
encouragement to
mothers on
methadone
maintenance
treatment programs
to promote
breastfeeding,
which is shown to
decrease NAS
symptoms in this
type of situation.

Additional information is
needed to accurately
explore this issue.
“[G]roup allocation was
self-selected according to
the type of infant feeding,
limiting the ability to
control for potentially
confounding variables”
(McQueen et al., 2011, p.
289).

Sample size: 44

Setting: Tertiary
care center in
Northwestern
Ontario

Design:
Retrospective
comparison
cohort study

Sampling
method: All
patient charts
that met criteria

Level of
Evidence: IV

Sample size: 28
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with non-breastfed
infants?
13. Newman, A., Davies,
G. A., Dow, K., Holmes,
B., Macdonald, J.,
McKnight, S., & Newton,
L. (2015). Rooming-in
care for infants of opioiddependent mothers:
Implementation and
evaluation at a tertiary
care hospital. Canadian
Family Physician, 61(12),
e555–e561. Retrieved
from
http://ezproxy.uakron.edu:
2048/login?url=http://sear
ch.ebscohost.com/login.as
px?direct=true&db=mnh&
AN=27035006&site=ehos
t-live

Purpose Statement: A
rooming-in program
was implemented to see
if increased contact
between opioiddependent women and
their infants had an
impact on NAS scores,
the need for
pharmacological
treatment, and length of
hospital stay.

Setting:
Kingston
General Hospital
in Ontario, Level
3 NICU

Research Question:
Does rooming-in
decrease the number of
infants experiencing
severe NAS symptoms,
the need for
pharmacological
interventions, and
length of hospital stay?

Sample size: 21
mother-infant
dyads

14. O’Connor, A. B.,
Collett, A., Alto, W. A., &
O’Brien, L. M. (2013).
Breastfeeding rates and
the relationship between
breastfeeding and neonatal
abstinence syndrome in
women maintained on
buprenorphine during
pregnancy. Journal of
Midwifery & Women’s
Health, 58(4), 383–388.

Purpose Statement: To
quantify breastfeeding
rates of pregnant
women dependent on
opioids who are on
buprenorphine and the
effects of breastfeeding
on pharmacological
standard of care.

Setting: Maine
General Medical
Center

Design:
Retrospective
cohort study

Sampling
method: All
patient charts
that met criteria

Level of
Evidence: IV

Research Question:
Does breastfeeding with

Sampling
method: All
patients of
opioid dependent
women at KGH
antenatal clinic

Sample size: 85
maternal-infant
pairs

Design:
Retrospective
comparison
cohort study
Level of
Evidence: IV

A drastic
decrease in
pharmacotherapy
was observed, as
the rate dropped
from 83.3% to
14.3% due to
rooming-in
efforts. Also, the
length of stay
dropped in this
scenario.

Through
implementation of a
program such as this
study described,
length of stay and
the need for
pharmacotherapy
can be decreased, as
well as an increase
in maternal
satisfaction.

NAS scoring tools are
subjective as the nurse
who is implementing
them uses their own
judgment. A small
sample size could have
impacted the results of
this study.

Breastfeeding
resulted in
decreased NAS
scores, and
infants were less
likely to receive
pharmacological
measures.

Promoting
breastfeeding
among mothers with
infants showing
signs of NAS is
important because
rates have
historically been
lower when the
mothers are on
methadone.

This was a retrospective
chart review. It is
difficult to determine the
effectiveness of
breastfeeding because
there were other factors
occurring simultaneously,
such as swaddling and
skin-to-skin contact.
Information related to
why or why not mothers
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43/10.1111/jmwh.12009

women on
buprenorphine during
pregnancy decrease the
duration, severity, and
frequency of
pharmacological
treatment of NAS?

15. Pritham, U. A., Paul, J.
A., & Hayes, M. J. (2012).
Opioid dependency in
pregnancy and length of
stay for neonatal
abstinence syndrome.
Journal of Obstetric,
Gynecologic & Neonatal
Nursing, 41(2), 180–190.
https://doiorg.ezproxy.uakron.edu:24
43/10.1111/j.15526909.2011.01330.x

Purpose Statement: This
study aimed to examine
the effects of
breastfeeding mothers
on neonatal outcomes
and length of stay.

16. Saiki, T., Lee, S.,
Hannam, S., &
Greenough, A. (2010).
Neonatal abstinence
syndrome--postnatal ward
versus neonatal unit
management. European
Journal Of Pediatrics,
169(1), 95–98.
https://doi.org/10.1007/s00
431-009-0994-0

Purpose Statement: The
goal was to test the idea
that caring for infants
with NAS in the same
room as their mothers
would decrease the
extent of treatment
needed and length of
stay.

Research Question:
Does implementing
breastfeeding with
infants of mothers who
had opioid replacement
therapy (methadone vs.
buprenorphine) during
pregnancy decrease
average length of stay
and NAS symptoms?

Research Question:
Does treating infants

33
breastfed was
unavailable.

Setting: Eastern
Maine Medical
Center’s Labor
and Delivery
Unit and NICU
Sampling
method: All
patient charts
that met criteria

Design:
Retrospective
comparison
cohort study
Level of
Evidence: IV

Sample size: 152

Setting: King’s
College Hospital
Sampling
method: All
patient charts
that met criteria
Sample size: 60
infants

Design:
Retrospective
comparison
cohort study
Level of
Evidence: IV

Breastfeeding
positively
impacted
(decreased) the
length of stay in
neonates
affected with
NAS, as well as
decreased the
rate of infant
pharmacological
treatment for
withdrawal.

Because NAS may
increase the need
for hospitalization
and ultimately
prevent early
bonding,
breastfeeding can
promote
maternal/infant
bonding and
attachment,
decrease the need
for NAS
pharmacological
treatment, and
decrease
hospitalization time.

This study was
performed by examining
medical records; thus,
prior documentation may
not have been a
completely accurate
representation of care.
Also, maternal drug use
was self-reported by the
women, which could lead
to decreased levels
reported, leading to
unreliable information.

“These results
suggest caring
for infants with
NAS on the
postnatal ward
rather than the
neonatal unit
reduces the need
for treatment and
duration of
hospital stay”

Rooming-in
programs should be
implemented when
caring for mothers
who abused drugs
during pregnancy to
shorten hospital
stays, instead of
admitting the infants
to the NICU.

The two different groups
in the study were
managed by different
teams, which could have
resulted in different
methods of care. Also,
this study was not
randomized, and it was a
retrospective study.
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with NAS on the
postnatal ward with
mothers, versus the
NICU, decrease
treatment need and
length, as well as length
of stay?
17. Schiff, D. M.,
Wachman, E. M., Philipp,
B., Joseph, K., Shrestha,
H., Taveras, E. M., &
Parker, M. G. K. (2018).
Examination of hospital,
maternal, and infant
characteristics associated
with breastfeeding
initiation and continuation
among opioid-exposed
mother-infant dyads.
Breastfeeding Medicine,
13(4), 266–274.
https://doiorg.ezproxy.uakron.edu:24
43/10.1089/bfm.2017.017
2

Purpose Statement: To
determine the number
of mothers who met
criteria for
breastfeeding per
hospital
recommendations and
to examine
breastfeeding initiation
rates associated with
maternal and infant
characteristics and
hospital initiatives.

18. Short, V. L., Gannon,
M., & Abatemarco, D. J.
(2016). The association
between breastfeeding and
length of hospital stay
among infants diagnosed
with neonatal abstinence
syndrome: A population-

Purpose Statement: This
study was conducted,
“to examine the
association between
breastfeeding and
length of hospital stay
among infants
diagnosed with NAS”

(Saiki et al.,
2010, p. 95).

Setting: Boston
Medical Center
Sampling
method: All
patient charts
that met criteria

Design:
Retrospective
comparison
cohort study
Level of
evidence: IV

Sample size: 564

Research Question:
Among infants exposed
with opioids in utero, do
hospital, maternal, and
infant characteristics
affect breastfeeding
rates and duration?
Setting:
Pennsylvania
Sampling
method: All
patient charts
that met criteria

Design:
Retrospective
comparison
cohort study
Level of
Evidence: IV

There was a
nearly three
times greater
odds of
breastfeeding
after initiation of
NAS quality
improvement
measures and
relaxation of
guideline
restrictions
regarding
breastfeeding
with opioidabusing mothers.

Breastfeeding
should be initiated
and continued after
hospital care.
Support groups and
proper education to
help continuation of
breastfeeding past
hospital stays can
help prevent a
decreased
percentage of
breastfeeding
mothers.

This was a retrospective
study. Breastfeeding
success may be hindered
by a common
characteristic of NAS: a
poor suck and latch
related to breastfeeding.
Tracking breastfeeding
initiatives and support
prior to care was not
possible in this study.

Breastfed infants
are found to
have shortened
hospitalizations
and decreased
incidence of
adverse effects
compared with

Supporting mothers
in breastfeeding and
communicating the
beneficial outcomes
can be beneficial for
infants with NAS
symptoms.

There was not enough
information regarding
exposure to
pharmacological
treatment during
pregnancy and
postpartum.
Classification and
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based study of in-hospital
births. Breastfeeding
Medicine, 11(7), 343–349.
https://doiorg.ezproxy.uakron.edu:24
43/10.1089/bfm.2016.008
4

(Short, Gannon, &
Abatemarco, 2016, p.
343)

19. Welle-Strand, G. K.,
Skurtveit, S., Jansson, L.
M., Bakstad, B., Bjarkø,
L., & Ravndal, E. (2013).
Breastfeeding reduces the
need for withdrawal
treatment in opioidexposed infants. Acta
Paediatrica, 102(11),
1060–1066. https://doiorg.ezproxy.uakron.edu:24
43/10.1111/apa.12378

Purpose Statement: To
assess whether
breastfeeding rates and
durations have an
impact on the symptoms
of NAS and the need for
pharmacological
treatment.

Setting:
Norwegian
Medical Birth
Registry and the
Norwegian
Center for
Addiction
Research

Research Question:
How are characteristics
of neonate outcomes
different from those
who breastfed versus
those who did not?

Sampling
method:
Recruitment
from OMT
centers

Purpose Statement: The
study attempted to
compare the number of
prenatal women who
said they wanted to
breastfeed to the
number who were
actually breastfeeding at
discharge, as well as

Setting:
University of
New Mexico
Hospital

Design:
Longitudinal
retrospective
cohort study

Sampling
method: All
patient charts
that met criteria

Level of
evidence: IV

20. Yonke, N., Maston, R.,
Weitzen, S., & Leeman, L.
(2018). Breastfeeding
intention compared with
breastfeeding postpartum
among women receiving
medication-assisted
treatment. Journal Of
Human Lactation, 1(1), 1-

Sample size:
3,725 NAS cases

non-breastfed
infants.

assessment of NAS
varies among healthcare
providers. The drugs used
in opioid dependence
treatment were not
identified, which could
impact the results.

Research Question: Is
there a significant
relationship between
breastfeeding and
hospital length of stay
for infants with NAS?
Design:
Comparison
study of a
cohort, 2
parts were
retrospective
Level of
Evidence: IV

Breastfeeding is
a positive
intervention for
infants exposed
to buprenorphine
or methadone in
utero. Lower
incidences of
NAS are also
associated with
breastfeeding.

As nurses, we
should encourage
people in this
population to
breastfeed, as well
as provide
information and
support for this
vulnerable group of
mothers and infants
on how to
breastfeed.

There was no theoretical
framework in this study.
The study was not as
accurate due to being a
retrospective study. The
children were born at 18
different hospitals, so
NAS scores could differ
as they were done by
different nurses. The
extent of breastfeeding
was not measured in the
questionnaire. The
buprenorphine sample
size was relatively small
to draw any significant
conclusions.

A decreased
need for
pharmacological
treatment was
found to be
associated with
breastfeeding
compared to
formula-feeding

Promotion of
breastfeeding in
women who have
neonates who are
experiencing NAS
symptoms is
important.
Education regarding
breastfeeding can be

Due to being a
retrospective study, there
was a lack of power and
qualitative data. No
information was present
on why breastfeeding
was initiated or stopped.

Sample size: 124
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analyzing the impacts of
breastfeeding on NAS
symptoms in the
affected neonates.
Research Question:
Does prenatal education
on breastfeeding with
women who are
dependent on opioids
during pregnancy
increase the likelihood
of continuing
breastfeeding after birth
and decrease the
symptoms of NAS in
newborns?

Sample size: 228

36
when analyzing
withdrawal
symptoms.

an asset to this type
of situation.

